Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study
The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker.
Gespeichert in:
| Autor*in: |
Pilat, N. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus - Wang, Hui ELSEVIER, 2022, Burlington, Mass |
|---|---|
| Übergeordnetes Werk: |
volume:41 ; year:2015 ; number:5 ; pages:683-689 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ejso.2015.02.003 |
|---|
| Katalog-ID: |
ELV023672587 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV023672587 | ||
| 003 | DE-627 | ||
| 005 | 20230623171145.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejso.2015.02.003 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015013000018.pica |
| 035 | |a (DE-627)ELV023672587 | ||
| 035 | |a (ELSEVIER)S0748-7983(15)00076-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.45 |2 bkl | ||
| 100 | 1 | |a Pilat, N. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study |
| 264 | 1 | |c 2015 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. | ||
| 650 | 7 | |a Colon cancer liver metastases |2 Elsevier | |
| 650 | 7 | |a Differentiation of prognostic and predictive value |2 Elsevier | |
| 650 | 7 | |a Biomarker TP53 |2 Elsevier | |
| 700 | 1 | |a Grünberger, T. |4 oth | |
| 700 | 1 | |a Längle, F. |4 oth | |
| 700 | 1 | |a Mittlböck, M. |4 oth | |
| 700 | 1 | |a Perisanidis, B. |4 oth | |
| 700 | 1 | |a Kappel, S. |4 oth | |
| 700 | 1 | |a Wolf, B. |4 oth | |
| 700 | 1 | |a Starlinger, P. |4 oth | |
| 700 | 1 | |a Kührer, I. |4 oth | |
| 700 | 1 | |a Mühlbacher, F. |4 oth | |
| 700 | 1 | |a Kandioler, D. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Harcourt |a Wang, Hui ELSEVIER |t Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |d 2022 |g Burlington, Mass |w (DE-627)ELV008984085 |
| 773 | 1 | 8 | |g volume:41 |g year:2015 |g number:5 |g pages:683-689 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejso.2015.02.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.45 |j Immunologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 41 |j 2015 |e 5 |h 683-689 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
n p np |
|---|---|
| matchkey_str |
pilatngrnbergertlnglefmittlbckmperisanid:2015----:sesntep3akryenainsraewtowtoteajvnceohrpfreetbeooetl |
| hierarchy_sort_str |
2015 |
| bklnumber |
44.45 |
| publishDate |
2015 |
| allfields |
10.1016/j.ejso.2015.02.003 doi GBVA2015013000018.pica (DE-627)ELV023672587 (ELSEVIER)S0748-7983(15)00076-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.45 bkl Pilat, N. verfasserin aut Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 Elsevier Grünberger, T. oth Längle, F. oth Mittlböck, M. oth Perisanidis, B. oth Kappel, S. oth Wolf, B. oth Starlinger, P. oth Kührer, I. oth Mühlbacher, F. oth Kandioler, D. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:41 year:2015 number:5 pages:683-689 extent:7 https://doi.org/10.1016/j.ejso.2015.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 41 2015 5 683-689 7 045F 610 |
| spelling |
10.1016/j.ejso.2015.02.003 doi GBVA2015013000018.pica (DE-627)ELV023672587 (ELSEVIER)S0748-7983(15)00076-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.45 bkl Pilat, N. verfasserin aut Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 Elsevier Grünberger, T. oth Längle, F. oth Mittlböck, M. oth Perisanidis, B. oth Kappel, S. oth Wolf, B. oth Starlinger, P. oth Kührer, I. oth Mühlbacher, F. oth Kandioler, D. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:41 year:2015 number:5 pages:683-689 extent:7 https://doi.org/10.1016/j.ejso.2015.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 41 2015 5 683-689 7 045F 610 |
| allfields_unstemmed |
10.1016/j.ejso.2015.02.003 doi GBVA2015013000018.pica (DE-627)ELV023672587 (ELSEVIER)S0748-7983(15)00076-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.45 bkl Pilat, N. verfasserin aut Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 Elsevier Grünberger, T. oth Längle, F. oth Mittlböck, M. oth Perisanidis, B. oth Kappel, S. oth Wolf, B. oth Starlinger, P. oth Kührer, I. oth Mühlbacher, F. oth Kandioler, D. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:41 year:2015 number:5 pages:683-689 extent:7 https://doi.org/10.1016/j.ejso.2015.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 41 2015 5 683-689 7 045F 610 |
| allfieldsGer |
10.1016/j.ejso.2015.02.003 doi GBVA2015013000018.pica (DE-627)ELV023672587 (ELSEVIER)S0748-7983(15)00076-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.45 bkl Pilat, N. verfasserin aut Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 Elsevier Grünberger, T. oth Längle, F. oth Mittlböck, M. oth Perisanidis, B. oth Kappel, S. oth Wolf, B. oth Starlinger, P. oth Kührer, I. oth Mühlbacher, F. oth Kandioler, D. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:41 year:2015 number:5 pages:683-689 extent:7 https://doi.org/10.1016/j.ejso.2015.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 41 2015 5 683-689 7 045F 610 |
| allfieldsSound |
10.1016/j.ejso.2015.02.003 doi GBVA2015013000018.pica (DE-627)ELV023672587 (ELSEVIER)S0748-7983(15)00076-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.45 bkl Pilat, N. verfasserin aut Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 Elsevier Grünberger, T. oth Längle, F. oth Mittlböck, M. oth Perisanidis, B. oth Kappel, S. oth Wolf, B. oth Starlinger, P. oth Kührer, I. oth Mühlbacher, F. oth Kandioler, D. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:41 year:2015 number:5 pages:683-689 extent:7 https://doi.org/10.1016/j.ejso.2015.02.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 41 2015 5 683-689 7 045F 610 |
| language |
English |
| source |
Enthalten in Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus Burlington, Mass volume:41 year:2015 number:5 pages:683-689 extent:7 |
| sourceStr |
Enthalten in Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus Burlington, Mass volume:41 year:2015 number:5 pages:683-689 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Immunologie |
| institution |
findex.gbv.de |
| topic_facet |
Colon cancer liver metastases Differentiation of prognostic and predictive value Biomarker TP53 |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| authorswithroles_txt_mv |
Pilat, N. @@aut@@ Grünberger, T. @@oth@@ Längle, F. @@oth@@ Mittlböck, M. @@oth@@ Perisanidis, B. @@oth@@ Kappel, S. @@oth@@ Wolf, B. @@oth@@ Starlinger, P. @@oth@@ Kührer, I. @@oth@@ Mühlbacher, F. @@oth@@ Kandioler, D. @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008984085 |
| dewey-sort |
3610 |
| id |
ELV023672587 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV023672587</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623171145.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejso.2015.02.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015013000018.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV023672587</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0748-7983(15)00076-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pilat, N.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Colon cancer liver metastases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Differentiation of prognostic and predictive value</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biomarker TP53</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grünberger, T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Längle, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mittlböck, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perisanidis, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kappel, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wolf, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Starlinger, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kührer, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mühlbacher, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kandioler, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Wang, Hui ELSEVIER</subfield><subfield code="t">Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus</subfield><subfield code="d">2022</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV008984085</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:41</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:683-689</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejso.2015.02.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">41</subfield><subfield code="j">2015</subfield><subfield code="e">5</subfield><subfield code="h">683-689</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Pilat, N. |
| spellingShingle |
Pilat, N. ddc 610 bkl 44.45 Elsevier Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study |
| authorStr |
Pilat, N. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008984085 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.45 bkl Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 Elsevier |
| topic |
ddc 610 bkl 44.45 Elsevier Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 |
| topic_unstemmed |
ddc 610 bkl 44.45 Elsevier Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 |
| topic_browse |
ddc 610 bkl 44.45 Elsevier Colon cancer liver metastases Elsevier Differentiation of prognostic and predictive value Elsevier Biomarker TP53 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t g tg f l fl m m mm b p bp s k sk b w bw p s ps i k ik f m fm d k dk |
| hierarchy_parent_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| hierarchy_parent_id |
ELV008984085 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008984085 |
| title |
Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study |
| ctrlnum |
(DE-627)ELV023672587 (ELSEVIER)S0748-7983(15)00076-1 |
| title_full |
Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study |
| author_sort |
Pilat, N. |
| journal |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| journalStr |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
683 |
| author_browse |
Pilat, N. |
| container_volume |
41 |
| physical |
7 |
| class |
610 610 DE-600 610 VZ 44.45 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Pilat, N. |
| doi_str_mv |
10.1016/j.ejso.2015.02.003 |
| dewey-full |
610 |
| title_sort |
assessing the tp53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: a p53 research group study |
| title_auth |
Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study |
| abstract |
The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. |
| abstractGer |
The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. |
| abstract_unstemmed |
The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
5 |
| title_short |
Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study |
| url |
https://doi.org/10.1016/j.ejso.2015.02.003 |
| remote_bool |
true |
| author2 |
Grünberger, T. Längle, F. Mittlböck, M. Perisanidis, B. Kappel, S. Wolf, B. Starlinger, P. Kührer, I. Mühlbacher, F. Kandioler, D. |
| author2Str |
Grünberger, T. Längle, F. Mittlböck, M. Perisanidis, B. Kappel, S. Wolf, B. Starlinger, P. Kührer, I. Mühlbacher, F. Kandioler, D. |
| ppnlink |
ELV008984085 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ejso.2015.02.003 |
| up_date |
2024-07-06T19:27:37.069Z |
| _version_ |
1803859061187280896 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV023672587</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623171145.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejso.2015.02.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015013000018.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV023672587</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0748-7983(15)00076-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pilat, N.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The type of a biomarker – whether it is prognostic or predictive – is frequently not known, although such information is crucial for assessing the clinical value of a marker.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Colon cancer liver metastases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Differentiation of prognostic and predictive value</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biomarker TP53</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grünberger, T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Längle, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mittlböck, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perisanidis, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kappel, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wolf, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Starlinger, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kührer, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mühlbacher, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kandioler, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Wang, Hui ELSEVIER</subfield><subfield code="t">Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus</subfield><subfield code="d">2022</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV008984085</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:41</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:683-689</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejso.2015.02.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">41</subfield><subfield code="j">2015</subfield><subfield code="e">5</subfield><subfield code="h">683-689</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3990326 |